Central Laboratory of the First Affiliated Hospital of Jinan University, Guangzhou, China.
Key Laboratory of Regenerative Biology, Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, Joint School of Life Sciences, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
Br J Pharmacol. 2018 May;175(9):1439-1450. doi: 10.1111/bph.14139. Epub 2018 Mar 14.
Increasing energy expenditure through adipocyte thermogenesis is generally accepted as a promising strategy to mitigate obesity and its related diseases. However, few clinically effective and safe agents are known to promote adipocyte thermogenesis. In this study, 20 traditional Chinese herbal medicines were screened to examine whether they induced adipocyte thermogenesis.
The effects of Chinese herbal medicines or components isolated from extracts of A. membranaceus, on adipocyte thermogenesis were analysed by assessing expression of uncoupling protein 1 (UCP1) by qPCR. Eight-week-old C57BL6/J male mice were fed a high-fat diet for 8 weeks and then randomized to two groups treated with vehicle or formononetin for another 8 weeks. Glucose tolerance tests and staining of adipose tissue with haematoxylin and eosin were carried out. Whole-body oxygen consumption was measured with an open-circuit indirect calorimetry system.
Extracts of A. membranaceus increased expression of Ucp1 in primary cultures of mouse adipocytes. Formononetin was the only known component of A. membranaceus extracts to increase adipocyte Ucp1 expression. Diet-induced obese mice treated with formononetin gained less weight and showed higher energy expenditure than untreated mice. In addition, formononetin binds directly with PPARγ.
Taken together, our study demonstrates that the Chinese herbal medicine from A. membranaceus and its constituent formononetin have the potential to reduce obesity and associated metabolic disorders. Our results suggest that formononetin regulates adipocyte thermogenesis as a non-classical PPARγ agonist.
通过脂肪细胞产热来增加能量消耗,通常被认为是减轻肥胖及其相关疾病的一种很有前途的策略。然而,目前已知的能够促进脂肪细胞产热的有效且安全的药物却很少。在这项研究中,我们筛选了 20 种中草药,以检验它们是否能诱导脂肪细胞产热。
通过 qPCR 检测解偶联蛋白 1(UCP1)的表达,分析中草药或从膜荚黄芪提取物中分离出的成分对脂肪细胞产热的影响。8 周龄 C57BL6/J 雄性小鼠用高脂肪饮食喂养 8 周,然后随机分为两组,分别用载体或芒柄花素治疗 8 周。进行葡萄糖耐量试验和苏木精和伊红染色的脂肪组织染色。用开路间接量热法系统测量全身耗氧量。
膜荚黄芪提取物能增加原代培养的小鼠脂肪细胞中 Ucp1 的表达。芒柄花素是膜荚黄芪提取物中唯一能增加脂肪细胞 UCP1 表达的已知成分。用芒柄花素治疗的饮食诱导肥胖小鼠比未治疗的小鼠体重增加较少,能量消耗较高。此外,芒柄花素直接与 PPARγ 结合。
综上所述,我们的研究表明,来自膜荚黄芪的中草药及其成分芒柄花素有潜力减轻肥胖及其相关代谢紊乱。我们的研究结果表明,芒柄花素作为一种非经典的 PPARγ 激动剂,调节脂肪细胞产热。